Prognostic factors for PFS identified in PTL
| Adverse prognostic factors for PFS in studies of PTL . | References . |
|---|---|
| Age >70 y | 7 |
| Advanced stage | 7, 11, 12, 64 |
| B symptoms | 11, 12, 92 |
| ECOG performance status >1 | 11, 92 |
| >1 extranodal site | 68 |
| Involvement of extranodal sites other than testis | 11, 68 |
| Tumor diameter >10 cm | 11 |
| Raised serum LDH | 11, 12 |
| Raised serum β2-microglobulin | 11, 12 |
| Hypoalbuminemia | 5 |
| Involvement of the left testis | 7, 92, 93 |
| Adverse prognostic factors for PFS in studies of PTL . | References . |
|---|---|
| Age >70 y | 7 |
| Advanced stage | 7, 11, 12, 64 |
| B symptoms | 11, 12, 92 |
| ECOG performance status >1 | 11, 92 |
| >1 extranodal site | 68 |
| Involvement of extranodal sites other than testis | 11, 68 |
| Tumor diameter >10 cm | 11 |
| Raised serum LDH | 11, 12 |
| Raised serum β2-microglobulin | 11, 12 |
| Hypoalbuminemia | 5 |
| Involvement of the left testis | 7, 92, 93 |
ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase.